Tarsus Pharmaceuticals, Inc. TARS Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Tarsus Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s operating margin?
- Tarsus Pharmaceuticals, Inc. (TARS) reported operating margin of -9.5% in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s operating margin changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s operating margin increased by 79.7% year-over-year, from -46.7% to -9.5%.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s operating margin?
- Over 4 years (2021 to 2025), Tarsus Pharmaceuticals, Inc.'s operating margin has grown at a -7.3% compound annual growth rate (CAGR), from -21.3% to -15.7%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.